Patent application number | Description | Published |
20130275530 | Reduced Latency Messaging For Mobile Communication Devices - A mobile electronic communication device includes a controller, memory, wireless transceiver, and output device supported by a housing. The controller executes a program with instructions stored in the memory and suspends execution of the program. The controller resumes execution of the program to retrieve a communication message from an online data storage service with the wireless transceiver in response to receiving a notification message with the wireless transceiver. The controller executes the program to retrieve a communication message and outputs the communication message with the output device. The mobile electronic communication device outputs messages with a reduced delay between transmission of the communication message and output of the communication message. | 10-17-2013 |
20140335823 | System And Method For Administration And Operation Of One Or More Mobile Electronic Communications Devices - A mobile electronic communications device includes a housing, a memory, a data entry mechanism, a display for visual data, at least one wireless transceiver configured to transmit and receive electromagnetic signals conforming to a plurality of wireless signaling protocols, and a controller. The controller is communicatively connected to the memory, data entry mechanism, and display; and is configured to send and receive data using the at least one wireless transceiver. The controller detects available wireless networks using at least one of the plurality of wireless signaling protocols, compares network identifications of available wireless networks to a predetermined list of network identifications ordered by preference, establishes a wireless network connection with an available wireless network having a network identification corresponding to a most preferred network identification in the predetermined list of network identifications, and executes an authentication process in response to establishing the wireless network connection. | 11-13-2014 |
20150358821 | SYSTEM AND METHOD FOR ADMINISTRATION AND OPERATION OF ONE OR MORE MOBILE ELECTRONIC COMMUNICATIONS DEVICES - A system for managing mobile electronic communications devices includes a user directory database configured to hold authentication data associated with at least one user, an authentication authority communicatively connected to the user directory database, an administration server configured to send and receive command messages with at least one mobile electronic communications device, a messaging server configured to send and receive communications messages with at least one mobile electronic communications device, and the authentication authority, administration server, and messaging server are configured to send and receive data via a data communications network. The authentication authority accepts or denies authentication data for a user received from at least one mobile electronic communications device, stores status information corresponding to authenticated users in the user directory database, and stores an association between each authenticated user and each mobile electronic device that sent authentication data for an authenticated user in the user directory database. | 12-10-2015 |
Patent application number | Description | Published |
20090068145 | Methods and Compositions Relating to Islet Cell Neogenesis - The present invention provides methods and kits for treating diseases and conditions associated with impaired pancreatic function. The present invention further provides methods of stimulating islet cell neogenesis and stimulating islet cell differentiation from progenitor cells. | 03-12-2009 |
20110280833 | PEPTIDES, DERIVATIVES AND ANALOGS THEREOF, AND METHODS OF USING SAME - Human proIslet Peptides (HIP) and HIP analogs and derivatives thereof, derived from or homologous in sequence to the human REG3A protein, chromosome 2p12, are able to induce islet neogenesis from endogenous pancreatic progenitor cells. Human proIslet Peptides are used either alone or in combination with other pharmaceuticals in the treatment of type 1 and type 2 diabetes and other pathologies related to aberrant glucose, carbohydrate, and/or lipid metabolism, insulin resistance, overweight, obesity, polycystic ovarian syndrome, eating disorders and the metabolic syndrome. | 11-17-2011 |
20130190233 | PEPTIDES, DERIVATIVES AND ANALOGS THEREOF, AND METHODS OF USING SAME - Human proIslet Peptides (HIP) and HIP analogs and derivatives thereof, derived from or homologous in sequence to the human REG3A protein, chromosome 2p12, are able to induce islet neogenesis from endogenous pancreatic progenitor cells. Human proIslet Peptides are used either alone or in combination with other pharmaceuticals in the treatment of type 1 and type 2 diabetes and other pathologies related to aberrant glucose, carbohydrate, and/or lipid metabolism, insulin resistance, overweight, obesity, polycystic ovarian syndrome, eating disorders and the metabolic syndrome. | 07-25-2013 |
20150018272 | COMPOSITIONS AND METHODS OF USING PROISLET PEPTIDES AND ANALOGS THEREOF - Embodiments relate to proislet peptides, preferably HIP, that exhibit increased stability and efficacy, and methods of using the same to treating a pathology associated with impaired pancreatic function, including type 1 and type 2 diabetes and symptoms thereof. | 01-15-2015 |
20150056167 | PEPTIDES, DERIVATIVES AND ANALOGS THEREOF, AND METHODS OF USING SAME - Human proIslet Peptides (HIP) and HIP analogs and derivatives thereof, derived from or homologous in sequence to the human REG3A protein, chromosome 2p12, are able to induce islet neogenesis from endogenous pancreatic progenitor cells. Human proIslet Peptides are used either alone or in combination with other pharmaceuticals in the treatment of type 1 and type 2 diabetes and other pathologies related to aberrant glucose, carbohydrate, andor lipid metabolism, insulin resistance, overweight, obesity, polycystic ovarian syndrome, eating disorders and the metabolic syndrome. | 02-26-2015 |
Patent application number | Description | Published |
20080300190 | PEPTIDES, DERIVATIVES AND ANALOGS THEREOF, AND METHODS OF USING SAME - Human proIslet Peptides (HIP) and HIP analogs and derivatives thereof, derived from or homologous in sequence to the human REG3A protein, chromosome 2p12, are able to induce islet neogenesis from endogenous pancreatic progenitor cells. Human proIslet Peptides are used either alone or in combination with other pharmaceuticals in the treatment of type 1 and type 2 diabetes and other pathologies related to aberrant glucose, carbohydrate, and/or lipid metabolism, insulin resistance, overweight, obesity, polycystic ovarian syndrome, eating disorders and the metabolic syndrome. | 12-04-2008 |
20100093605 | PEPTIDES, DERIVATIVES AND ANALOGS THEREOF, AND METHODS OF USING SAME - Human proIslet Peptides (HIP) and HIP analogs and derivatives thereof, derived from or homologous in sequence to the human REG3A protein, chromosome 2p12, are able to induce islet neogenesis from endogenous pancreatic progenitor cells. Human proIslet Peptides are used either alone or in combination with other pharmaceuticals in the treatment of type 1 and type 2 diabetes and other pathologies related to aberrant glucose, carbohydrate, and/or lipid metabolism, insulin resistance, overweight, obesity, polycystic ovarian syndrome, eating disorders and the metabolic syndrome. | 04-15-2010 |
Patent application number | Description | Published |
20120313759 | Tracking system for persons and/or objects - An RFID-based tracking system that tracks persons and/or objects of interest without the need for triangulation techniques is disclosed. The system tracks persons and/or objects of interest by utilizing RFID antennas having a relatively small field of view and positioned relative to functional areas of a facility and/or within passageways between functional areas of the facility. The persons and/or objects of interest to be tracked are provided with an RFID tag. The present invention provides the system user with the ability to determine whether the persons and/or objects of interest are present within a particular functional area of the facility regardless of whether the presence of the person and/or object of interest is continuously detected by the system. | 12-13-2012 |
20140210617 | System to facilitate well-being checks - A system for checking the well-being of individuals within an institution is disclosed. The system is comprised of portable wireless devices in the possession of individual(s) who are to perform the well-being checks, a wireless communication network, and a computer device that is connected to the portable wireless devices by the wireless communication network. The computer device executes well-being software and is provided with well-being databases containing the well-being checks to be performed for each person, and has access to a tracking system. The tracking system determines the location of the person on whom such well-being checks are to be performed, the individual performing such well-being checks, and monitors and records whether such well-being checks have been performed. | 07-31-2014 |
20150015407 | Display system for tracking large numbers of persons and/or objects - A display system for tracking large numbers of persons or objects in real-time is disclosed. The display system utilizes a tracking system that employs various types of technologies, such as RFID, to determine the location of the person and/or objects being tracked. The displays of the present invention utilize colors, graphics, and the physical groupings of related data on a display device, usually a computer monitor, to present tracking information in a compact, readily changeable, and easily analyzed format in real-time. | 01-15-2015 |
Patent application number | Description | Published |
20100069730 | System and Methods for Improved Diabetes Data Management and Use Employing Wireless Connectivity Between Patients and Healthcare Providers and Repository of Diabetes Management Information - Methods, devices and a system for disease management are provided that employ diagnostic testing devices (e.g., blood glucose meters) and medication delivery devices (e.g., insulin delivery devices) for providing data to a repository in real-time and automatically. Repository data can be analyzed to determine such information as actual test strip use, patient health parameters to outside prescribed ranges, testing and medication delivery compliance, patient profiles or stakeholders to receive promotional items or incentives, and so on. Connected meters and medication delivery devices and repository data analysis are also employed to associate a diagnostic test to a mealtime based on timing of a therapeutic intervention performed by an individual. | 03-18-2010 |
20110071475 | OUTER COVER OF A PEN NEEDLE FOR A DRUG DELIVERY PEN - A connecting member removably connects a plurality of pen needles together, thereby providing a convenient way for a patient to carry multiple pen needles. The connecting member may be integrally formed with the outer cover of the pen needle or may be a separate member that removably receives the pen needle. An outer cover of a pen needle is provided with gripping means to facilitate gripping and handling of the outer cover. A lid connects to the outer cover to seal the outer cover. The lid also has gripping means to facilitate gripping and handling the lid. A cap is provided that has a first opening for receiving a first end of the outer cover and a second opening for receiving a second end of the outer cover. | 03-24-2011 |
20120029469 | Lubricated pen needle - A pen needle ( | 02-02-2012 |
20130030841 | System and Methods for Improved Diabetes Data Management and Use Employing Wireless Connectivity Between Patients and Healthcare Providers and Repository of Diabetes Management Information - Methods, devices and a system for disease management are provided that employ diagnostic testing devices (e.g., blood glucose meters) and medication delivery devices (e.g., insulin delivery devices) for providing data to a repository in real-time and automatically. Repository data can be analyzed to determine such information as actual test strip use, patient health parameters to outside prescribed ranges, testing and medication delivery compliance, patient profiles or stakeholders to receive promotional items or incentives, and so on. Connected meters and medication delivery devices and repository data analysis are also employed to associate a diagnostic test to a mealtime based on timing of a therapeutic intervention performed by an individual. | 01-31-2013 |
20140350487 | OUTER COVER OF A PEN NEEDLE FOR A DRUG DELIVERY PEN - A connecting member removably connects a plurality of pen needles together, thereby providing a convenient way for a patient to carry multiple pen needles. The connecting member may be integrally formed with the outer cover of the pen needle or may be a separate member that removably receives the pen needle. An outer cover of a pen needle is provided with gripping means to facilitate gripping and handling of the outer cover. A lid connects to the outer cover to seal the outer cover. The lid also has gripping means to facilitate gripping and handling the lid. A cap is provided that has a first opening for receiving a first end of the outer cover and a second opening for receiving a second end of the outer cover. | 11-27-2014 |